dehydrocorydaline

1. Dehydrocorydaline (13-Methylpalmatine) exerts anti-metastatic potential via suppression of MMPs and Bcl-2 signaling in NSC-LC cells. 2. Dehydrocorydaline stimulates p38 MAPK activation, which can enhance heterodimerization of MyoD and E proteins, thus resulting in MyoD activation and myoblast differentiation. 3. Dehydrocorydaline shows antiplatelet effects, it inhibits thrombin-induced platelet aggregation in a low dose ( IC50= 34.914 ug/mL). 4. Dehydrocorydaline has anti-inflammatory and antinociceptive effects. 5. Dehydrocorydaline inhibits MCF-7 cell proliferation by inducing apoptosis mediated by regulating Bax/Bcl-2, activating caspases as well as cleaving PARP.

Dehydrocorydaline chloride (13-Methylpalmatine chloride) is an alkaloid exhibiting anti-inflammatory and anti-cancer activities and can enhance the activation of p38 MAPK.

1. Dehydrocorydaline(DHC) not only inhibits antibody-mediated allergic reactions but also influences cell-mediated allergic reactions, and the inhibitory effect of Corydalis Tuber on allergic reactions may be partially attributed to DHC. 2. Dehydrocorydal

Dehydrocavidine (Dehydrocorydaline) has antitumor activity, it inhibits MCF-7 cell proliferation by inducing apoptosis mediated by regulating Bax/Bcl-2, activating caspases as well as cleaving PARP.

Dehydrocorydaline hydroxyl (13-Methylpalmatine) is an alkaloid that modulates the expression of Bax and Bcl-2 proteins, activates caspase-7 and caspase-8, and inactivates PARP. It enhances the activation of p38 MAPK and exhibits anti-inflammatory and anticancer properties. Additionally, it shows potent antimalarial activity with low cytotoxicity (cell viability > 90%) against the P. falciparum 3D7 strain (IC50 = 38 nM).

TBHQ (tert-Butylhydroquinone) is an antioxidant that induces an antioxidant response through the redox-sensitive transcription factor Nrf2.

TBHQ-d12 (tert-Butylhydroquinone-d12) is a deuterium-labeled form of TBHQ. This compound, known as TBHQ (tert-Butylhydroquinone), is a widely used Nrf2 activator that protects against heart toxicity induced by Doxorubicin (DOX) through Nrf2 activation. Additionally, TBHQ acts as an ERK activator, counteracting the inhibitory effects of Dehydrocorydaline (DHC) on melanoma cell proliferation.

TBHQ (Standard) is the standard substance of TBHQ, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. TBHQ (tert-Butylhydroquinone) is an antioxidant that induces an antioxidant response through the redox-sensitive transcription factor Nrf2.

Dehydrocavidine (Standard) is a reference standard for research and analysis in studies involving Dehydrocavidine. Dehydrocavidine (Dehydrocorydaline) has antitumor activity, it inhibits MCF-7 cell proliferation by inducing apoptosis mediated by regulating Bax/Bcl-2, activating caspases as well as cleaving PARP.